RAP 0.00% 20.5¢ resapp health limited

Ann: Best and Final Confirmation and Bridging Loan, page-116

  1. 26,627 Posts.
    lightbulb Created with Sketch. 1727
    So not "no revenue at all" as you stated???? and from the last quarterly "Research and development payments increased to $1,625,000 (Q3: $410,000) due to the additional costs for recruitment in US and India COVID-19 studies during the quarter. Advertising and marketing costs decreased to $55,000 (Q3: $70,000). Staff costs remained approximately constant at $1,050,000 (Q3: $1,018,000). Administration and corporate costs increased to $766,000 (Q3: $257,000) due to costs associated with recent corporate and transactional activity"
    Last edited by AlCp: 17/08/22
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.